Publications by authors named "Daniel Primo"

Claim this Profile
I
Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15.
Rafael Alonso Fernandez, Jessica Encinas Mayoral, Laetitia Pierre-Louis, Yao Yao, Yan Xu, Daniel Primo

Blood Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia.
Joaquín Martínez-López, Pau Montesinos, Nieves López-Muñoz, Rosa Ayala, Pilar Martínez-Sánchez, Daniel Primo

Med Int (Lond)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms.
Alicia Arenas Cortés, Rosa Ayala Diaz, Pilar Hernández-Campo, Julián Gorrochategui, Daniel Primo

Haematologica· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia.
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Joaquín Martínez López, Juan Miguel Bergua, Mar Tormo, Daniel Primo

Mediterr J Hematol Infect Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Gabriela Rodríguez, Jaime Pérez-Oteyza, Daniel Primo

Leuk Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.
Daniel Primo, Lydia Scarfò, Aliki Xochelli, Mattias Mattsson, Pamela Ranghetti

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Discovery Testing Compounds in Patient Samples by Automated Flow Cytometry.
Pilar Hernández, Julián Gorrochategui, Daniel Primo, Alicia Robles, José Luis Rojas

SLAS Technol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
Ana-Alicia López-Iglesias, Ana B Herrero, Marta Chesi, Laura San-Segundo, Lorena González-Méndez, Daniel Primo

J Hematol Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine.
Teresa A Bennett, Pau Montesinos, Federico Moscardo, David Martinez-Cuadron, Joaquin Martinez, Daniel Primo

Clin Lymphoma Myeloma Leuk· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisursodeoxycholate(ethylenediamine)platinum(II): a new autofluorescent compound. Cytotoxic activity and cell cycle analysis in ovarian and hematological cell lines.
Martín Pérez-Andrés, Juan J Benito, Emilio Rodríguez-Fernández, Bruna Corradetti, Daniel Primo

Dalton Trans· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
Daniel Primo, Juan Flores, Sandra Quijano, María Luz Sanchez, María Eugenia Sarasquete

Br J Haematol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lineage involvement in chronic myeloid leukaemia: comparison between MBCR/ABL and mBCR/ABL cases.
Daniel Primo, Maria Luz Sanchez, Ana Belén Espinosa, María Dolores Tabernero, Ana Rasillo

Br J Haematol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Her-2/neu gene amplification in familial vs sporadic breast cancer. Impact on the behavior of the disease.
Ana B Espinosa, Maria D Tabernero, Maria C García-Macías, Daniel Primo, Amalia Gómez Bernal

Am J Clin Pathol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis